Literature DB >> 12695043

Development of a diagnostic PCR assay based on novel DNA sequences for the detection of Mycoplasma suis (Eperythrozoon suis) in porcine blood.

Ludwig E Hoelzle1, Dagmar Adelt, Katharina Hoelzle, Karl Heinritzi, Max M Wittenbrink.   

Abstract

An efficient method of control of porcine eperythrozoonosis (PE) caused by Mycoplasma suis is eradication of infection by detection and removal of infected carrier animals. At present, only a few tests are available for the diagnosis of these latent M. suis infections in pigs. The objective of this study was to develop a PCR assay based on novel DNA sequences for the identification of M. suis-infected pigs. A 1.8 kb EcoRI DNA fragment of the M. suis genome was isolated from the blood of pigs experimentally infected with M. suis. Specificity of the DNA fragment was confirmed by DNA sequence analysis and PCR using primers directed against sequences contained in the 1.8 kb fragment. PCR products of 782 bp in size were amplified only from M. suis particles prepared from the blood of experimentally infected pigs but not from any controls, comprising blood from gnotobiotic piglets and a panel of bacteria including other porcine mycoplasmas. PCR results were confirmed by dot blot hybridisation. The applicability of the PCR assay to diagnose M. suis infections in pigs was evaluated by investigating blood samples from 10 symptomatic pigs with clinical signs typical of porcine eperythrozoonosis and blood samples from 10 healthy pigs. The M. suis-specific PCR product was amplified from all samples taken at episodes of acute disease as well as from samples taken during the latent stage of infection, thus demonstrating the suitability of the PCR assay for detecting latent infected carrier animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695043     DOI: 10.1016/s0378-1135(03)00040-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

1.  Antigen specificity of the humoral immune response to Mycoplasma haemofelis infection.

Authors:  Iain R Peters; Chris R Helps; Timothy J Gruffydd-Jones; Michael J Day; Séverine Tasker
Journal:  Clin Vaccine Immunol       Date:  2010-06-02

2.  Alteration of integrin-associated protein (CD47) on experimental porcine eperythrozoonosis.

Authors:  Wei Li; Ning Du; Binrui Xu; Weixing Dong; Zhe Qu; Yong Wang; Yanping Sui
Journal:  Vet Res Commun       Date:  2008-02-23       Impact factor: 2.459

3.  Mycoplasma suis antigens recognized during humoral immune response in experimentally infected pigs.

Authors:  L E Hoelzle; K Hoelzle; M Ritzmann; K Heinritzi; M M Wittenbrink
Journal:  Clin Vaccine Immunol       Date:  2006-01

4.  Phylogenetic analysis of Mycoplasma suis isolates based on 16S rRNA gene sequence in China.

Authors:  Rong-Qiong Zhou; Kui Nie; Han-Cheng Huang; Shi-jun Hu; Zuo-yong Zhou; Hong-Lin Luo
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

5.  Inorganic pyrophosphatase in uncultivable hemotrophic mycoplasmas: identification and properties of the enzyme from Mycoplasma suis.

Authors:  Katharina Hoelzle; Simone Peter; Michele Sidler; Manuela M Kramer; Max M Wittenbrink; Kathrin M Felder; Ludwig E Hoelzle
Journal:  BMC Microbiol       Date:  2010-07-20       Impact factor: 3.605

6.  Effect of an immunosuppressor (dexamethasone) on eperythrozoon infection.

Authors:  C Yuan; Z Yang; J Zhu; L Cui; X Hua
Journal:  Vet Res Commun       Date:  2007-02-07       Impact factor: 2.459

7.  Identification of B cell epitopes in the MSG1 protein of Mycoplasma suis.

Authors:  Chen Chang; Yao Zou; Yufeng Li
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

8.  "Candidatus Mycoplasma haemomacaque" and Bartonella quintana bacteremia in cynomolgus monkeys.

Authors:  Ricardo G Maggi; Patricia E Mascarelli; Nandhakumar Balakrishnan; Cynthia M Rohde; Catherine M Kelly; Lila Ramaiah; Michael W Leach; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

9.  Use of recombinant antigens to detect antibodies against Mycoplasma suis, with correlation of serological results to hematological findings.

Authors:  Katharina Hoelzle; Julia Grimm; Mathias Ritzmann; Karl Heinritzi; Paul Torgerson; Anja Hamburger; Max M Wittenbrink; Ludwig E Hoelzle
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

10.  Mycoplasma suis infection results endothelial cell damage and activation: new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma.

Authors:  Albina Sokoli; Katrin Groebel; Katharina Hoelzle; Werner M Amselgruber; José M Mateos; Mårten K J Schneider; Urs Ziegler; Kathrin M Felder; Ludwig E Hoelzle
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.